Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,891 | 162 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $441.14 | 25 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $351.10 | 21 | $0 (2022) |
| Amgen Inc. | $270.83 | 12 | $0 (2023) |
| Lilly USA, LLC | $237.63 | 15 | $0 (2024) |
| Novo Nordisk Inc | $221.41 | 12 | $0 (2024) |
| PFIZER INC. | $198.36 | 12 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $152.67 | 8 | $0 (2023) |
| Amarin Pharma Inc. | $129.36 | 6 | $0 (2022) |
| Medtronic, Inc. | $114.01 | 5 | $0 (2024) |
| ABBVIE INC. | $105.76 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $303.42 | 14 | Novo Nordisk Inc ($78.49) |
| 2023 | $340.29 | 20 | GlaxoSmithKline, LLC. ($109.49) |
| 2022 | $409.65 | 24 | Novo Nordisk Inc ($80.36) |
| 2021 | $217.04 | 13 | PFIZER INC. ($66.96) |
| 2020 | $477.48 | 26 | AstraZeneca Pharmaceuticals LP ($185.93) |
| 2019 | $246.89 | 15 | GlaxoSmithKline, LLC. ($91.74) |
| 2018 | $522.49 | 25 | Amgen Inc. ($175.03) |
| 2017 | $373.90 | 25 | GlaxoSmithKline, LLC. ($58.48) |
All Payment Transactions
162 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Azurity Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.75 | General |
| 10/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $30.48 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Diabetes | ||||||
| 06/28/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Diabetes Care | ||||||
| 05/22/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.04 | General |
| 05/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Gastroenterology | ||||||
| 05/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $31.13 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Diabetes | ||||||
| 03/06/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 02/20/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Endocrinology | ||||||
| 02/15/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: VACCINES | ||||||
| 01/10/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/20/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: VACCINES | ||||||
| 11/15/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: VACCINES | ||||||
| 11/02/2023 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Ophthalmology | ||||||
| 11/02/2023 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $4.43 | General |
| Category: Ophthalmology | ||||||
| 10/25/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/04/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Inflammation | ||||||
| 09/06/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: RESPIRATORY | ||||||
| 08/02/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Neuroscience | ||||||
| 07/26/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Diabetes | ||||||
| 07/05/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 2,945 | 4,496 | $387,032 | $202,183 |
| 2022 | 30 | 3,034 | 4,323 | $401,341 | $206,152 |
| 2021 | 32 | 3,025 | 4,248 | $394,365 | $212,348 |
| 2020 | 32 | 2,932 | 3,857 | $316,568 | $153,267 |
All Medicare Procedures & Services
123 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 418 | 959 | $155,358 | $76,840 | 49.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 283 | 283 | $50,940 | $34,469 | 67.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 298 | 298 | $40,230 | $23,117 | 57.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 129 | 176 | $38,368 | $21,368 | 55.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 131 | 132 | $9,900 | $9,616 | 97.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 365 | 735 | $7,350 | $6,166 | 83.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 19 | $5,700 | $5,360 | 94.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 293 | 293 | $7,618 | $4,960 | 65.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 81 | $9,126 | $4,276 | 46.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 134 | 135 | $4,050 | $3,872 | 95.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 83 | 114 | $6,726 | $2,481 | 36.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 126 | 173 | $6,055 | $1,672 | 27.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,500 | $1,386 | 39.6% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 34 | 34 | $5,100 | $1,198 | 23.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 15 | $1,955 | $651.00 | 33.3% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 21 | 45 | $1,170 | $615.95 | 52.6% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 15 | 16 | $1,295 | $500.64 | 38.7% |
| 74021 | X-ray of abdomen, minimum of 3 views | Office | 2023 | 15 | 17 | $1,224 | $472.80 | 38.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 16 | 16 | $533.00 | $458.88 | 86.1% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 26 | 27 | $1,350 | $437.40 | 32.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 12 | 12 | $1,276 | $430.87 | 33.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 133 | 572 | $22,880 | $411.54 | 1.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 76 | 105 | $2,100 | $354.64 | 16.9% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 13 | 13 | $1,001 | $327.72 | 32.7% |
| 73560 | X-ray of knee, 1-2 views | Office | 2023 | 13 | 13 | $741.00 | $279.24 | 37.7% |
About Dr. Ryan Turner, MD
Dr. Ryan Turner, MD is a Family Medicine healthcare provider based in Blanchard, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780613109.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Turner, MD has received a total of $2,891 in payments from pharmaceutical and medical device companies, with $303.42 received in 2024. These payments were reported across 162 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($2,891).
As a Medicare-enrolled provider, Turner has provided services to 11,936 Medicare beneficiaries, totaling 16,924 services with total Medicare billing of $773,950. Data is available for 4 years (2020–2023), covering 123 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Blanchard, OK
- Active Since 06/30/2006
- Last Updated 06/23/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1780613109
Products in Payments
- ANORO (Drug) $151.76
- FARXIGA (Drug) $146.32
- Vascepa (Drug) $129.36
- Repatha (Biological) $123.56
- TRELEGY ELLIPTA (Drug) $118.06
- INTELLIS ADAPTIVESTIM (Device) $114.01
- TRULICITY (Drug) $108.59
- SYMBICORT (Drug) $108.48
- ENTRESTO (Drug) $101.75
- SHINGRIX (Biological) $85.25
- MOUNJARO (Drug) $77.30
- Prolia (Biological) $71.08
- VRAYLAR (Drug) $68.41
- STIOLTO RESPIMAT (Drug) $66.77
- SOLIQUA (Drug) $63.07
- Aimovig (Biological) $62.79
- CHANTIX (Drug) $61.72
- Ozempic (Drug) $55.08
- PREVNAR 13 (Biological) $54.50
- BREZTRI (Drug) $49.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Blanchard
Dr. Steven Bander, Do, DO
Family Medicine — Payments: $5,339
Misty Bogle, M.d, M.D
Family Medicine — Payments: $403.20
James Swanson, M.d, M.D
Family Medicine — Payments: $79.02
Kayeleigh Baskin, Md, MD
Family Medicine — Payments: $50.70
Dr. Karl Pecht, M.d, M.D
Family Medicine — Payments: $44.27